Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: An explanation for liver disease

American Journal of Pathology

Volumn 168, Issue 4, 2006, Pages 1299-1308

  Kruse, Kristina B ^a   Dear, Amy ^b   Kaltenbrun, Erin R ^a   Crum, Brandan E ^a   George, Peter M ^b   Brennan, Stephen O ^b   McCracken, Ardythe A ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AGUADILLA; ARGININE; FIBRINOGEN; FIBRINOGEN VARIANT; MUTANT PROTEIN; POLYPEPTIDE; TRYPTOPHAN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOPHAGY; CELL VACUOLE; ENDOPLASMIC RETICULUM; HYPOFIBRINOGENEMIA; LIVER CIRRHOSIS; LIVER DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN TARGETING; SACCHAROMYCES CEREVISIAE; TRANS GOLGI NETWORK;

EID: 33645451010     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.051097     Document Type: Article

References (58)

1. Mosesson MW: Fibrinogen and fibrin structure and function. J Thromb Haemost 2005, 3:1894-1904
2. Weisel JW: Fibrinogen and fibrin. Adv Protein Chem 2005, 70:247-299
3. Roy S, Yu S, Banerjee D, Overton O, Mukhopadhyay G, Oddoux C, Grieninger G, Redman CM: Assembly and secretion of fibrinogen: degradation of individual chains. J Biol Chem 1992, 267:23151-23158
4. Huang S, Cao Z, Chung DW, Davie EW: The role of betagamma and alphagamma complexes in the assembly of human fibrinogen. J Biol Chem 1996, 271:27942-27947
5. Redman CM, Xia H: Fibrinogen biosynthesis: assembly, intracellular degradation, and association with lipid synthesis and secretion. Ann NY Acad Sci 2001, 936:480-495
6. Xia H, Redman CM: The degradation of nascent fibrinogen chains is mediated by the ubiquitin proteasome pathway. Biochem Biophys Res Commun 1999, 261:590-597
7. Brennan SO, Fellowes AP, George PM: Molecular mechanisms of hypo- and afibrinogenemia. Ann NY Acad Sci 2001, 936:91-100
8. Callea F, Brisigotti M, Fabbretti G, Bonino F, Desmet VJ: Hepatic endoplasmic reticulum storage diseases. Liver 1992, 12:357-362
9. Brennan SO, Wyatt J, Medicina D, Callea F, George PM: Fibrinogen brescia: hepatic endoplasmic reticulum storage and hypofibrinogenemia because of a gamma284 Gly→Arg mutation. Am J Pathol 2000, 157:189-196
10. Brennan SO, Maghzal G, Shneider BL, Gordon R, Magid MS, George PM: Novel fibrinogen gamma375 Arg→Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology 2002, 36:652-658
11. Crystal RG: Alpha 1-antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy. J Clin Invest 1990, 85:1343-1352
12. Sveger T: The natural history of liver disease in alpha 1-antitrypsin deficient children. Acta Paediatr Scand 1988, 77:847-851
13. Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter DH: A lag in intracellular degradation of mutant alpha-1-antitrypsin correlates with the liver disease phentotype in homozygous PiZZ individuals. Proc Natl Acad Sci USA 1994, 91:9014-9018
14. Lomas DA, Mahadeva R: α1-Antitrypsin polymerization and the serpinopathies: pathobiology and the prospects for therapy. J Clin Investig 2002, 110:1585-1590
15. Perlmutter DH: Alpha1-antitrypsin deficiency: liver disease associated with retention of a mutant secretory glycoprotein in the endoplasmic reticulum. Protein Misfolding and Disease, Principles and Protocols. Edited by P Brass, N Gregersen. Totowa, NJ, Humana Press, 2003, pp 39-56
16. Eriksson S: A 30-year perspective on alpha 1-antitrypsin deficiency. Chest 1996, 110:237S-242S
17. Teckman JH, Burrows J, Hidvegi T, Schmidt B, Hale PD, Perlmutter DH: The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes. J Biol Chem 2001, 276:44865-44872
18. Werner ED, Brodsky JL, McCracken AA: Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate. Proc Natl Acad Sci USA 1999, 93:13797-13801
19. Kruse KB, Brodsky JL, McCracken AA: Characterization of an ERAD gene as VPS30/ATG6 reveals two alternative and functionally distinct protein quality control pathways: one for soluble A1PiZ and another for aggregates of A1PiZ. Mol Biol Cell 2005, 17:203-212
20. Teckman JH, Perlmutter DH: Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 2000, 279:G961-G974
21. Yee VC, Pratt KP, Cote HC, Trong IL, Chung DW, Davie EW, Stenkamp RE, Teller DC: Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen. Structure 1997, 15:125-138
22. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, Bangham R, Benito R, Boeke JD, Bussey H, Chu AM, Connelly C, Davis K, Dietrich F, Dow SW, El Bakkoury M, Foury F, Friend SH, Genialen E, Giaever G, Hegemann JH, Jones T, Laub M, Liao H, Liebundguth N, Lockhart DJ, Lucau-Danila A, Lussier M, M'Rabet N, Menard P, Mittmann M, Pai C, Rebischung C, Revuelta JL, Riles L, Roberts CJ, Ross-MacDonald P, Scherens B, Snyder M, Sookhai-Mahadeo S, Storms RK, Veronneau S, Voet M, Volckaert G, Ward TR, Wysocki R, Yen GS, Yu K, Zimmermann K, Philippsen P, Johnston M, Davis RW: Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999, 285:901-906
23. Heinemeyer W, Gruhler A, Mohrle V, Mahe Y, Wolf DH: PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chrymotryptic activity and degradation of ubiquitinated proteins. J Biol Chem 1993, 268:5115-5120
24. Brodsky JL, Schekman R: A Sec63p-BiP complex from yeast is required for protein translocation in a reconstituted proteoliposome. J Cell Biol 1993, 123:1355-1363
25. Lishko VK, Yakubenko VP, Hertzberg KM, Grieninger G, Ugarova TP: The alternatively spliced alpha(E)C domain of human fibrinogen-420 is a novel ligand for leukocyte integrins alpha(M)beta(2) and alpha(X)beta(2). Blood 2001, 98:2448-2455
26. Mumberg D, Müller R, Funk M: Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res 1994, 22:5767-5768
27. Clare JJ, Rayment FB, Ballantine SP, Sreekrishna K, Romanos MA: High-level expression of tetanus toxin fragment-C in Pichia-pastoris strains containing multiple tandem integrations of the gene. BioTechnology 1991, 9:455-460
28. Adams A, Gottschling DE, Kaiser CA, Stearns T: Techniques and protocols: high-efficiency transformation of yeast. Methods in Yeast Genetics. Edited by MM Dickerson. New York, Cold Spring Harbor Press, 1997, pp 99-102
29. McCracken AA, Karpichev IV, Ernaga JE, Werner ED, Dillin AG, Courchesne WE: Yeast mutants deficient in ER-associated degradation of the Z variant of alpha-1-protease inhibitor. Genetics 1996, 144:1355-1362
30. McCracken AA, Kruse KB: Selective protein degradation in the yeast exocytic pathway. Mol Biol Cell 1993, 4:729-736
31. Brodsky JL, Lawrence JG, Caplan AJ: Mutations in the cytosolic DnaJ homologue, YDJ1, delay and compromise the efficient translation of heterologous proteins in yeast. Biochemistry 1998, 37:18045-18055
32. Brennan SO: Electrospray ionisation analysis of human fibrinogen. Thromb Haemost 1997, 78:1055-1058
33. Hubbard MJ, Mchugh NJ, Carne DL: Isolation of ERp29, a novel endoplasmic reticulum protein, from rat enamel cells: evidence for a unique role in secretory-protein synthesis. Eur J Biochem 2000, 267:1945-1956
34. Kabani M, Kelley SS, Morrow MW, Montgomery DL, Sivendran R, Rose MD, Gierasch LM, Brodsky JL: Dependence of endoplasmic reticulum-associated degradation on the peptide binding domain and concentration of BiP. Mol Biol Cell 2003, 14:3437-3448
35. Schmidt BZ, Perlmutter DH: Grp78, Grp94 and Grp170 interact with alpha-1-antitrypsin mutants that are retained in the endoplasmic reticulum. Am J Physiol Gastrointest Liver Physiol 2005, 289:G444-G455
36. Caplan S, Green R, Rocco J, Kurjan J: Glycosylation and structure of the yeast MF alpha 1 alpha-factor precursor is important for efficient transport through the secretory pathway. J Bacteriol 1991, 173:627-635
37. Farrell DH, Huang S, Davie EW: Processing of the carboxyl 15-amino acid extension in the alpha-chain of fibrinogen. J Biol Chem 1993, 268:10351-10355
38. Brennan SO, Hammonds B, George PM: Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val → Asp). J Clin Invest 1995, 96:2854-2858
39. Xia H, Redman CM: Differential degradation of the three fibrinogen chains by proteasomes: involvement of Sec61p and cytosolic Hsp70. Arch Biochem Biophys 2001, 390:137-145
40. Spear ED, Ng DT: Stress tolerance of misfolded carboxypeptidase Y requires maintenance of protein trafficking and degradative pathways. Mol Biol Cell 2003, 14:2756-2767
41. Hong E, Davidson AR, Kaiser CA: A pathway for targeting soluble misfolded proteins to the yeast vacuole. J Cell Biol 1996, 135:623-633
42. Holkeri H, Makarow M: Different degradation pathways for heterologous glycoproteins in yeast. FEBS Lett 1998, 429:162-166
43. Jorgensen MU, Emr SD, Winther JR: Ligand recognition and domain structure of Vps10p, a vacuolar protein sorting receptor in Saccharomyces cerevisiae. Eur J Biochem 1999, 260:461-469
44. Coughlan CM, Walker JL, Cochran JC, Wittrup KD, Brodsky JL: Degradation of mutated bovine pancreatic trypsin inhibitor (BPTI) in the yeast vacuole suggests post-endoplasmic reticulum protein quality control. J Biol Chem 2004, 279:15289-15297
45. Arvan P, Zhao X, Ramos-Castaneda J, Chang A: Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems. Traffic 2002, 3:771-780
46. Jones EW, Zubenko GS, Parker RR: PEP4 gene function is required for expression of several vacuolar hydrolases in Saccharomyces cerevisiae. Genetics 102:665-677, 1982
47. Lomas DA, Evans DL, Finch JT, Carrell RW: The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992, 357:605-607
48. Dafforn TR, Mahadeva R, Elliott PR, Sivasothy P, Lomas DA: A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem 1999, 274:9548-9555
49. Kihara A, Noda T, Ishihara N, Ohsumi Y: Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J Cell Biol 2001, 152:519-530
50. Wurmser AE, Emr SD: Novel PtdIns(3)P-binding protein Etf1 functions as an effector of the Vps34 Ptdlns 3-kinase in autophagy. J Cell Biol 2002, 158:761-772
51. Johnston JA, Ward CL, Kopito RR: Aggresomes: a cellular response to misfolded proteins. J Cell Biol 1998, 143:1883-1898
52. Kopito RR: Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 2000, 10:524-530
53. Garcia-Mata R, Gao YS, Sztul E: Hassles with taking out the garbage: aggravating aggresomes. Traffic 2002, 3:388-396
54. Teckman JH, Qu D, Perlmutter DH: Molecular pathogenesis of liver disease in alpha1-antitrypsin deficiency. Hepatology 1996, 24:1504-1516
55. Tarabal O, Caldero J, Casas C, Oppenheim RW, Esquerda JE: Protein retention in the endoplasmic reticulum, blockade of programmed cell death and autophagy selectively occur in spinal cord motoneurons after glutamate receptor-mediated injury. Mol Cell Neurosci 2005, 29:283-298
56. Liu Y, Vollrath D: Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma. Hum Mol Genet 2004, 13:1193-1204
57. Castino R, Davies J, Beaucourt S, Isidoro C, Murphy D: Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene. FASEB J 2005, 19:1021-1023
58. Coughlan CM, Brodsky JL: Use of yeast as a model system to investigate protein conformational diseases. Mol Biotechnol 2005, 30:171-180